首頁 > 市場調查報告書 > 醫療設備

整形外科關節移植

市場調查報告書

商品編碼

1606509

全球髖關節與膝關節重建市場 - 2024-2031

Global Hips & Knees Reconstructive Market - 2024-2031

出版日期: 2024年12月04日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球髖關節和膝關節重建市場達到173億美元，預計2031年將達到229.3億美元，2024-2031年預測期間複合年成長率為3.6%。

髖關節和膝關節重建手術是一種外科手術，旨在恢復受到骨關節炎、類風濕性關節炎、事故或其他退化性疾病等疾病影響的髖關節和膝關節的功能和完整性。這些治療通常需要用模仿健康關節自然活動性和功能的人造植入物來取代受損的關節部件。髖關節和膝關節重建手術的兩種主要類型是全關節置換和部分關節置換。全關節置換包括去除所有受損的關節表面並用稱為假體的人造部件替換它們。這些義肢經過精確構造，可以模仿健康關節的形狀和運動。

老年人口盛行率的增加是預測期內推動市場的促進因素。例如，根據泛美衛生組織的數據，全球預計將有 2,000 萬人新診斷癌症，1,000 萬人因癌症死亡。未來二十年，癌症負擔將增加近 60%，給醫療保健系統、個人和社區帶來進一步的負擔。例如，根據聯合國的統計，全球 65 歲及以上的人口數量預計將增加一倍以上，從 2021 年的 7.61 億增至 2050 年的 16 億。。人口老化是不可逆轉的全球趨勢。

市場動態：

驅動程式和限制

老年人口增加

老年人口的增加預計將成為全球髖關節和膝關節重建市場成長的重要因素。隨著人口老化，骨關節炎和類風濕性關節炎等與年齡相關的關節疾病的盛行率增加。這些疾病經常引起相當大的疼痛、活動受限和生活品質下降，促使許多老年人尋求髖關節和膝關節置換等手術治療。研究表明，儘管出現問題的風險較高，但老年患者越來越傾向於接受髖關節和膝關節置換術，因為這些治療在減輕疼痛和增強功能方面具有顯著的好處。此外，手術技術和植入技術的改進使這些手術對老年人來說更安全、更成功。

例如，據世界衛生組織稱，到2050年，80%的老年人將生活在低收入和中等收入國家。人口老化的速度比過去快得多。 2020年，60歲及以上的人口數量超過了5歲以下的兒童數。 2015年至2050年間，全球60歲以上人口比例將增加近一倍，從12%增加至22%。到 2030 年，世界上每 6 人就有 1 人年齡在 60 歲或以上。此時60歲及以上人口的比例將從2020年的10億增加到14億。到 2050 年，全球 60 歲及以上人口將增加一倍（21 億）。 2020 年至 2050 年間，80 歲及以上的人口數量預計將增加兩倍，達到 4.26 億。

植入和手術的高成本

植入物和手術的高成本等因素預計將阻礙全球髖關節和膝關節重建市場。植入物和外科手術的高成本是行業成長的主要障礙。這些財務限制可能會阻礙獲得重要治療，特別是對於低收入患者或沒有完整醫療保險的患者。全髖關節置換術（THA）和全膝關節置換術（TKA）手術費用昂貴，術前檢查、手術和術後復健加在一起通常要花費數千美元。

Hip and knee reconstructive procedures are surgical interventions designed to restore the function and integrity of hip and knee joints that have been affected by disorders such as osteoarthritis, rheumatoid arthritis, accident, or other degenerative diseases. These treatments usually entail replacing damaged joint components with artificial implants that mimic the natural mobility and function of healthy joints. The two main types of hip and knee reconstructive procedures are total joint replacement and partial joint replacement. Total joint replacement involves removing all damaged joint surfaces and replacing them with artificial components known as prostheses. These prostheses are precisely constructed to mimic the shape and movement of healthy joints.

The increasing prevalence of geriatric population is the driving factor that drives the market over the forecast period. For instance, according to the Pan American Health Organization, globally, there were an expected 20 million new cancer diagnoses and 10 million cancer deaths. Over the next two decades, the cancer burden will rise by almost 60%, putting a further burden on healthcare systems, individuals, and communities. For instance, according to the United Nations, The number of people aged 65 years or older worldwide is projected to more than double, rising from 761 million in 2021 to 1.6 billion in 2050. The number of people aged 80 years or older is growing even faster. Population ageing is an irreversible global trend.

Market Dynamics: Drivers & Restraints

Increasing geriatric population

The increasing geriatric population is expected to be a significant factor in the growth of the global hips & knees reconstructive market. As the population ages, the prevalence of age-related joint diseases such osteoarthritis and rheumatoid arthritis increases. These diseases frequently cause considerable pain, restricted mobility, and a lower quality of life, driving many senior people to seek surgical treatments such as hip and knee replacements. According to research, despite being at a higher risk of problems, older patients are becoming more inclined to undergo hip and knee replacements due to the significant benefits these treatments provide in terms of pain reduction and enhanced functionality. Furthermore, improvements in surgical techniques and implant technology have made these surgeries safer and more successful for older people.

For instance, according to WHO, in 2050, 80% of older people will be living in low- and middle-income countries. The pace of population aging is much faster than in the past. In 2020, the number of people aged 60 years and older outnumbered children younger than 5 years. Between 2015 and 2050, the proportion of the world's population over 60 years will nearly double from 12% to 22%. By 2030, 1 in 6 people in the world will be aged 60 years or over. At this time the share of the population aged 60 years and over will increase from 1 billion in 2020 to 1.4 billion. By 2050, the world's population of people aged 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million.

High Costs of Implants and Procedures

Factors such as high costs of implants and procedures are expected to hamper the global hips & knees reconstructive market. The high cost of implants and surgical procedures is a major hindrance to industry growth. These financial constraints can impede access to important therapies, especially for low-income patients or those without complete health insurance coverage. Total hip arthroplasty (THA) and total knee arthroplasty (TKA) operations can be expensive, frequently costing several thousand dollars when pre-operative examinations, surgery, and post-operative rehabilitation are all added together.

Segment Analysis

The global hips & knees reconstructive market is segmented based on knee replacement, hip replacement, fixation method, end-user, and region.

Knee replacement segment is expected to dominate the global hips & knees reconstructive market share

The knee replacement segment is expected to dominate the global hips and knees reconstructive market, owing to the rising prevalence of knee-related disorders and the increasing desire for effective surgical solutions. As osteoarthritis and other degenerative joint illnesses become more frequent, particularly among the elderly, the demand for knee replacements is increasing rapidly. This tendency is bolstered by the acceptance of knee replacement procedures as realistic solutions for regaining mobility and improving quality of life.

Advances in medical technology have also contributed significantly to the expansion of the knee replacement market. Innovations such as minimally invasive surgical techniques and improved implant designs have made operations safer and more effective, resulting in improved patient outcomes. These innovations not only extend the life of implants, but also appeal to a broader spectrum of patients, including younger people who are increasingly seeking knee replacements due to their active lives.

For instance, in June 2024, Meril, a Gujarat-based medical devices company, has launched an indigenously developed surgical robotic technology, MISSO, which will provide assistance to doctors during knee replacement surgeries in real-time. It is expected to make these surgeries up to 66 per cent budget friendly.

Geographical Analysis

North America is expected to hold a significant position in the global hips & knees reconstructive market share

North America is expected to hold a significant portion of the global hips & knees reconstructive market. North America is likely to maintain its dominant position in the worldwide hips and knees reconstructive market, owing to a mix of demographic trends, technological improvements, and a strong healthcare infrastructure. The region's aging population is one of the key drivers of the rising need for joint reconstruction surgeries. As people age, they become more prone to musculoskeletal problems like arthritis, which frequently demand surgical interventions such as hip and knee replacements. This demographic transition not only increases the need for these procedures, but also emphasizes the importance of appropriate healthcare solutions suited to elderly people.

For instance, according to urban.org, the number of Americans aged 65 and older will more than double over the next 40 years, reaching 80 million in 2040. The number of adults ages 85 and older, the group most often needing help with basic personal care, will nearly quadruple between 2000 and 2040. For an instance, according to America Health Ranking.org, 17.3% of the entire US population is geriatric population.

Asia Pacific is growing at the fastest pace in the global hips & knees reconstructive market

Asia Pacific is experiencing the fastest growth in global hips & knees reconstructive owing to the increasing incidence of chronic diseases and technological advancements in the region. The Asia Pacific region is experiencing the fastest growth in the global hips and knees reconstructive market, owing to a combination of demographic shifts, increased healthcare investments, and growing awareness of joint health. The aging population in many of the region's countries is one of the most significant contributors to its rapid growth. As life expectancy rises and birth rates fall, a bigger proportion of the population enters the elderly age bracket, which coincides with a higher prevalence of joint-related diseases like osteoarthritis.

The increasing geriatric population is one of the driving factors in this region making it the fastest growing region. For instance, according to the UNFPA India, he current elderly population of 153 million (aged 60 and above) is expected to reach a staggering 347 million by 2050.

Competitive Landscape

The major global players in the global hips & knees reconstructive market include F. Hoffmann-La Roche Ltd, Abbott, Hologic, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Revvity, Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Illumina, Inc., and Sysmex Corporation among others.

Emerging Players

Genomtec, QuantiLight, and GeneSys Bio among others

Key Developments

In April 2024, Kharadi's Manipal Hospital launched robotic knee replacement surgery, promising better accuracy and quicker recovery. Manipal Hospital, Kharadi has unveiled advanced robotic knee replacement surgery, promising improved precision, faster recovery times, and reduced pain compared to traditional procedures.
In October 2024, Smith+Nephew announced that it launched its Legion hinged knee (HK) system with Oxinium implant technology in the U.S. Oxinium implant technology helps to mitigate the common risk factors associated with revision procedures. Legion revision with Oxinium delivers high-performing bearing with low risks of re-revision compared to the class average.

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global hips & knees reconstructive market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2023

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Knee Replacement
3.2. Snippet by Hip Replacement
3.3. Snippet by Fixation Method
3.4. Snippet by End-User
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Increasing Geriatric Population
- 4.1.2. Restraints
  - 4.1.2.1. High Costs of Implants and Procedures
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Knee Replacement

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Knee Replacement
- 6.1.2. Market Attractiveness Index, By Knee Replacement
6.2. Total Knee Systems*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Partial Knee System
6.4. Revision Knee Systems

7. By Hip Replacement

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hip Replacement
- 7.1.2. Market Attractiveness Index, By Hip Replacement
7.2. Total Hip Systems *
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Partial Hip Systems
7.4. Revision Hip Systems

8. By Fixation Method

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fixation Method
- 8.1.2. Market Attractiveness Index, By Fixation Method
8.2. Cemented Fixation*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Cementless Fixation
8.4. Hybrid Fixation

9. By End-User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 9.1.2. Market Attractiveness Index, By End-User
9.2. Hospitals & Clinics*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centers
9.4. Orthopedic Clinics
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Knee Replacement
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hip Replacement
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fixation Method
- 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.8.1. The U.S.
  - 10.2.8.2. Canada
  - 10.2.8.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Knee Replacement
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hip Replacement
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fixation Method
- 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.8.1. Germany
  - 10.3.8.2. UK
  - 10.3.8.3. France
  - 10.3.8.4. Italy
  - 10.3.8.5. Spain
  - 10.3.8.6. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Knee Replacement
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hip Replacement
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fixation Method
- 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.8.1. Brazil
  - 10.4.8.2. Argentina
  - 10.4.8.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Knee Replacement
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hip Replacement
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fixation Method
- 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 10.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.8.1. China
  - 10.5.8.2. India
  - 10.5.8.3. Japan
  - 10.5.8.4. South Korea
  - 10.5.8.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product and Service
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Knee Replacement
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Hip Replacement
- 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fixation Method
- 10.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Zimmer Biomet*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. DePuy Synthes
12.3. Smith & Nephew plc.
12.4. Stryker
12.5. MicroPort Scientific Corporation
12.6. B. Braun Melsungen AG
12.7. Exactech Inc.
12.8. Limacorporate S.p.a.
12.9. CeramTec
12.10. ConforMIS

LIST NOT EXHAUSTIVE